Immune response to synthetic peptides of dengue prM protein
Susana Vázquez(Instituto de Medicina Tropical “Pedro Kourí”), Mayling Álvarez(Instituto de Medicina Tropical “Pedro Kourí”), Maritza Pupo(Instituto de Medicina Tropical “Pedro Kourí”), Ana Beatriz Alvarez Pérez(Instituto de Medicina Tropical “Pedro Kourí”), Iselys Delgado(Instituto de Medicina Tropical “Pedro Kourí”), Glay Chinea, Hilda Garay, Gissel Garcı́a(Instituto de Medicina Tropical “Pedro Kourí”), R. Martinez Rodriguez(Instituto de Medicina Tropical “Pedro Kourí”), Gerardo Guillén(Hunan City University), Marı́a Guadalupe Guzmán(Instituto de Medicina Tropical “Pedro Kourí”), Osvaldo Reyes
Cited by 79
Related Papers
Evaluation of diagnostic tests: dengue
|Nature Reviews Microbiology|2010|588
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139